Haemonetics Corp. (hae 2.5 06/01/29)
13F holders, Q2 2026 (June 30)12holders +2
4new positions
2sold out
$1.01avg. 13F price*
At the end of Q2 2026, 12 institutions reported holding Haemonetics Corp. (hae 2.5 06/01/29) in their 13F filings, up 2 from Q1 2026. 4 opened new positions and 2 sold out. The largest holders were State of Wisconsin Investment Board ($4.0M), Income Research & Management ($3.3M) and Bank of New York Mellon Corp ($202K).
- Company
- Haemonetics Corp. (hae 2.5 06/01/29)
- CUSIP
- 405024AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $33K |
| Exits | 2 | $5.0M |
All 13F filers, Q1 2026 → Q2 2026: 1,032,464 shares bought and 5,727,025 shares sold, net −4,694,561 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| State of Wisconsin Investment Board | 0.01% | Add +33.3% | 4,000,000 | $4.0M |
| Income Research & Management | 1.81% | No change | 3,270,000 | $3.3M |
| Bank of New York Mellon Corp | 0.00% | Reduce -69.2% | 200,000 | $202K |
| Cetera Investment Advisers | 0.00% | No change | 86,000 | $87K |
| &partners | 0.00% | No change | 79,000 | $80K |
| Choreo, LLC | 0.00% | No change | 33,000 | $33K |
| Crestwood Advisors Group, LLC | 0.00% | New | 20,000 | $20K |
| Mariner, LLC | 0.00% | No change | 16,000 | $16K |
| Lanark Financial, Inc. | 0.00% | New | 6,000 | $6K |
| Natixis | 0.00% | New | 5,000 | $5K |
| Laffer Tengler Investments, Inc. | 0.00% | New | 1,464 | $1K |
| Oddo BHF Asset Management Sas | 0.00% | Reduce -14.3% | 150 | $152 |
"% of holder's portfolio" is HAEMONETICS CORP (HAE 2.5 06/01/29)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 2.5 06/01/29) the manager owns.